Certified by Founder
Lodge
BlossomHill Therapeutics, Inc.
start up
United States
- San Diego, California
- 17/12/2025
- Series B
- $84,000,000
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D., and biotech business veteran, Y. Peter Li, Ph.D., M.B.A. BlossomHill Therapeutics, Inc. is headquartered in San Diego, California.
- Industry Biotechnology Research
- Website https://bhtherapeutics.com/
- LinkedIn https://www.linkedin.com/company/blossomhill-therapeutics-inc/
Lemon Slice | $10,500,000 | (Jan 7, 2026)
Truemed | $34,000,000 | (Jan 7, 2026)
Ciphero | $2,500,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)